Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: The toxicity and side effects caused by adjuvant chemotherapy (ACT) after radical surgery for lung adenocarcinoma (LAC) lead to early termination frequently. This study was conducted to provide an objective basis for the effect of Chinese herbal medicine formulas (CHMFs) combined with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qin, Jiao, Lijing, Wang, Shengfei, Chen, Peiqi, Bi, Ling, Zhou, Di, Yao, Jialin, Li, Jiaqi, Wang, Liyu, Chen, Zhiwei, Jia, Yingjie, Zhang, Ziwen, Shen, Weisheng, Zhu, Weirong, Xu, Jianfang, Gao, Yong, Xu, Ling, Gong, Yabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049384/
https://www.ncbi.nlm.nih.gov/pubmed/32140080
http://dx.doi.org/10.1186/s12575-020-00117-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049384/
https://www.ncbi.nlm.nih.gov/pubmed/32140080
http://dx.doi.org/10.1186/s12575-020-00117-5

Ejemplares similares